Organogenesis Holding (ORGO) Tops Q3 EPS by 11c

Organogenesis Holding (NASDAQ: ORGO) reported Q3 EPS of $0.09, $0.11 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $115.2 million versus the consensus estimate of $108.83 million.

GUIDANCE:

Organogenesis Holding sees FY2024 revenue of $455-480 million, versus the consensus of $456 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink
• Edgewell stock surges on report of rejected takeover bid